- Home
- GH vs AVY Comparison
GH vs AVY Comparison
Compare GH & AVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GH | AVY |
|---|---|---|
| Founded | 2011 | 1935 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3B | 14.3B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | GH | AVY |
|---|---|---|
| Price | $131.72 | $158.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 9 |
| Target Price | $119.79 | ★ $205.56 |
| AVG Volume (30 Days) | ★ 2.4M | 611.3K |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | ★ 6.74 | 0.69 |
| EPS | N/A | ★ 2.18 |
| Revenue | ★ $982,021,000.00 | N/A |
| Revenue This Year | $33.30 | $5.70 |
| Revenue Next Year | $28.27 | $3.66 |
| P/E Ratio | ★ N/A | $72.86 |
| Revenue Growth | ★ 32.88 | N/A |
| 52 Week Low | $40.36 | $152.42 |
| 52 Week High | $135.00 | $199.54 |
Technical Indicators
Market Signals| Indicator | GH | AVY |
|---|---|---|
| Relative Strength Index (RSI) | 65.11 | 48.64 |
| Support Level | $122.76 | $153.78 |
| Resistance Level | $134.28 | $163.79 |
| Average True Range (ATR) | 6.05 | 3.73 |
| MACD | -1.11 | 0.72 |
| Stochastic Oscillator | 71.83 | 54.87 |
Price Performance
Historical ComparisonAbout GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About AVY Avery Dennison Corporation
Avery Dennison manufactures pressure-sensitive materials, merchandise tags, and labels. The company also runs a specialty converting business that produces radio-frequency identification inlays and labels. Avery Dennison draws a significant amount of revenue from outside the United States, with international operations accounting for the majority of total sales.